Skip to main content

Table 1 Demographic of TB patients and controls

From: No impact of helminth coinfection in patients with smear positive tuberculosis on immunoglobulin levels using a novel method measuring Mycobacterium tuberculosis-specific antibodies

 

Peru

Sweden

 

Endemic

Helminth-

Helminth+

Non-endemic

 

control

TB+

TB+

control

n

30

42

19

10

MODS

All neg.

All pos.

All pos.

NA

AFB

All neg.

All pos.

All pos.

NA

Helminth

All Helm. neg.

All Helm. neg.

All Helm. pos.

NA

Age Median (R)

27(18–76)

29.50(18–79)

33(19–70)

53.5(26–57)

p-value*

 

NS

NS

P = 0.0245

Gender Male (%)

18(60)

27(64.29)

13(68.42)

3(30)

p-value*

 

NS

NS

NS

CRP (mg/ml) Median (R)

1.475 (0.090–27.83)

53.65 (0.770–216.9)

52.09 (0.40–120)

0.530 (0.130–3.60)

p-value*

 

P = 0.0001

P = 0.0001

NS

Total IgE (ng/ml) Median (R)

236 (16.5–715)

273 (26.8–702)

367 (22.1–978)

25.3 (4.71–217)

p-value*

 

NS

NS

P = 0.0012

  1. TB, tuberculosis; AFB, Acid Fast Bacilli; MODS, Microscopic Observation Drug susceptibility; R, Range; NA, not analyzed; neg, negative; NS, not significant; CRP, C reactive protein; P: significant difference to Peru control; n: numbers; Helm. neg, helminth negative; Helm. pos, helminth positive. *Statistics performed with Kruskal-Wallis test